Nicorette Invisipatch (Nicotine)

Nicotine, the active ingredient in Nicorette Invisipatch, is a nicotine replacement therapy presented as a transdermal patch for transdermal use. It helps adults who smoke to reduce withdrawal symptoms and cravings while they work toward quitting permanently.

GNH USA supplies Nicorette Invisipatch as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance and reliable logistics for global health partners. Our network spans Europe, Asia, Africa and the Americas, facilitating timely delivery and support for nicotine cessation programs.

Nicotine delivered via the Nicorette Invisipatch is employed in nicotine replacement therapy to aid smoking cessation.

- Smoking cessation: assists adults who smoke to quit by alleviating withdrawal symptoms and cravings. - Relapse prevention: supports individuals who have quit to maintain abstinence and avoid relapse. - Reduction of nicotine dependence: enables a gradual decrease in nicotine intake over time. - Support during quit attempts: provides a steady nicotine supply to reduce the urge to smoke during critical quitting periods. - Adjunct to behavioral counseling: enhances the effectiveness of counseling or support programs aimed at quitting smoking.

Common Side Effects: - Skin irritation at the application site: redness, itching, or mild rash. - Localized burning or tingling sensation where the patch is applied. - Headache: often mild and transient. - Sleep disturbances: vivid dreams or difficulty falling asleep.

Serious or Rare Side Effects: - Allergic reaction: swelling, hives, or severe rash. - Cardiovascular events: palpitations, chest pain, or hypertension. - Dizziness or fainting episodes. - Severe skin reactions: blistering or extensive dermatitis. - Nausea or vomiting that persists.

Precautions should be observed when using Nicorette Invisipatch. - Cardiovascular assessment: evaluate patients with recent heart attack, angina, or uncontrolled hypertension before initiating therapy. - Pregnancy and lactation: use only if the potential benefit outweighs the risk; consult a healthcare professional. - Non‑smokers: avoid use in individuals who are not nicotine dependent. - Concomitant nicotine use: do not use other nicotine products while wearing the patch. - Children and pets: keep out of reach to prevent accidental exposure. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Potential drug interactions should be considered.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase the risk of hypertensive episodes. - Certain antihypertensive agents: nicotine can counteract blood‑pressure‑lowering effects, leading to uncontrolled hypertension. - Insulin or oral hypoglycemics: nicotine may affect glucose metabolism, requiring close monitoring.

Moderate Interactions (Monitor Closely): - CYP1A2 substrates (e.g., theophylline, clozapine): nicotine may induce metabolism, reducing drug efficacy. - Beta‑blockers: nicotine can blunt the heart‑rate‑lowering response, necessitating dose adjustments.